Cortexyme

$49.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.81 (+1.67%) Today

$0.00 (0.00%) As of 11:14 AM UTC after-hours

Why Robinhood?

You can buy or sell Cortexyme and other stocks, options, and ETFs commission-free!

About CRTX

Cortexyme, Inc. Common Stock, also called Cortexyme, is a biopharmaceutical company, which develops therapeutics based on data supporting a new theory of the cause of Alzheimer's and other neurodegenerative disorders. Its product, COR388, is in clinical trial. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA. The listed name for CRTX is Cortexyme, Inc. Common Stock.

CEO

Casey Crawford Lynch

Employees

Headquarters

South San Francisco, California

Founded

2012

Market Cap

1.46B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

135.55K

High Today

$49.33

Low Today

$47.37

Open Price

$48.68

Volume

91.93K

52 Week High

$73.84

52 Week Low

$25.59

Collections

Analyst Ratings

71%

of 7 ratings

Buy

71%

Hold

14%

Sell

14%

CRTX Earnings

-$0.73

-$0.49

-$0.24

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 16, After Hours